Some investors may be asking whether CVS Health offers good value at around its recent price, or whether much of the potential upside in the stock has already been realized. Over the past year, CVS ...
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Jefferies sets a 'Buy' on Shriram Finance, citing strong CV demand and growth outlook—discover the latest target and rationale here.
CVS Health (NYSE:CVS) has launched Health100, an AI powered digital health platform, through a new subsidiary. The platform is being developed in major partnership with Google Cloud to connect ...
StockStory.org on MSN
3 cash-producing stocks with questionable fundamentals
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of ...
CEO Mark Bertolini has been making the same promise for four consecutive quarters: 2026 is the year the company turns profitable. Now, with the Q4 2025 results in hand, we can see exactly what he’s ...
The retirement of David Cordani as CEO of The Cigna Group will be the fourth departure of a long-time health insurance ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Gilead Sciences (GILD – Research Report), Janux Therapeutics Inc (JANX – Resea ...
Young and the Invested on MSN
7 great stocks you can find on the discount rack
This article discusses the best value stocks right now.
It was a week that reminded investors how quickly the Magnificent 7 can splinter. AI optimism and fresh earnings momentum ...
What’s better than getting to buy 6.6%-11% yields at discounted prices? How about snapping those sweet dividend payers while ...
Explore SPYD ETF: 4%+ yield, 0.07% fees, real estate-heavy income focus, returns vs. SCHD/DGRO, and rate-cut upside/risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results